| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0306 |
| Document Type: 4 |
| Period of Report: 5/18/20 |
| Issuer: |
| Issuer CIK: 887247 |
| Issuer Name: Adamis Pharmaceuticals Corp |
| Issuer Trading Symbol: ADMP |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1461736 |
| | Owner Name: Hopkins Robert O |
| Reporting Owner Address: |
| | Owner Street 1: C/O ADAMIS PHARMACEUTICALS CORPORATION |
| | Owner Street 2: 11682 EL CAMINO REAL, STE 300 |
| | Owner City: SAN DIEGO |
| | Owner State: CA |
| | Owner ZIP Code: 92130 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? No |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: Chief Financial Officer |
| | Other Text: |
| Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 5/18/20 |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: S |
| | | Equity Swap Involved? No |
| | | Footnote ID: F1 |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 6,532 |
| Footnote ID: F2 |
| | | Transaction Price Per Share: |
| Value: 0.5601 |
| Footnote ID: F3 |
| | | Transaction Acquired-Disposed Code: |
| Value: D |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 302,199 |
| Footnote ID: F4 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Footnotes: |
| Footnote - F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| Footnote - F2: The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person. |
| Footnote - F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.5502 to $0.585, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| Footnote - F4: Includes shares of common stock beneficially owned and shares of common stock issuable upon vesting of restricted stock units previously reported in Table 1 of Form 4. |
| Remarks: |
| Owner Signature: |
| Signature Name: /s/Robert O. Hopkins, Power of Attorney for Robert O Hopkins |
| Signature Date: 5/20/20 |
